CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4 Grant or award EVP, Quality & Ethics, and CPL acquired 62,500 shares (grant or award)
- 4 Shares withheld for taxes SVP, Bioservices gave up 292 shares (to pay taxes)
- POS AM Other Post-effective Amendment for Registration Statement
- POS EX Other Post-effective Amendment
- 424B3 Offering Prospectus
- 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 313 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Products Business gave up 498 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,756 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes SVP, General Counsel, Corp Sec gave up 918 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Other events
- 4 Grant or award SVP, R&D, CMO acquired 29,482 shares (grant or award)
- 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 18,674 shares (to pay taxes)
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
Page 9 of 87 · 1,733 filings